Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Badal-Faesen S et al, Pre-cART Evaluation of CRP and CD4+ T-Cell Immune Activation Associated with HIV Clinical Progression in a multi-national case-cohort study. 70(2): 163-171.

Blanchard K, Lince-Deroche N, Fetters T, et al. Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study. Contraception, 2015; 92: 330–338.

Bohlius J, Maskew M, Davies MA and Egger M. HHV-8 seroprevalence in HIV-positive and HIV-negative populations. Int J Cancer 2015. 136(5): 1243.

Bohlius J, Maxwell N, Spoerri A, Wainwright R, Sawry S, Poole J, Eley B, Prozesky H, Rabie H, Garone D, Technau KG, Maskew M, Davies MA, Davidson A, Stefan DC, Egger M; for IeDEA-Southern Africa. Incidence of AIDS-Defining and Other Cancers in HIV-Positive Children in South Africa: Record Linkage Study. Pediatr Infect Dis J. 2016 Feb 19.

Bor J, Moscoe E, Bärnighausen T. Three approaches to causal inference in regression discontinuity designs. Epidemiology, 2015; 26(2), e28-e30.

Bor J, Geldsetzer P, Venkataramani A, Bärnighausen T. Quasi-experiments to establish causal effects of HIV care and treatment and to improve the cascade of care. Current Opinion in HIV/AIDS, 2015; 10 (6) 495–501.

Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, Tanser, F, Pillay D, Bärnighausen T.Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa. PLoS Med, 2015; 12(11): e1001905.

Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, Tanser F, Pillay D, Bärnighausen T. Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa. PLOS Medicine, 2015; 12(11): 1-21.

Budgell E, Maskew M, Long L, Sanne I, Fox MP. Does Most Mortality in Patients on ART Occur in Care or After Lost to Follow-Up? Evidence From the Themba Lethu Clinic, South Africa. J Acquir Immune Defic Syndr, 2015; 70(3), 323-328.
PMID: 27725021

BudgellE,SchnippelK,Rosen S, IveP.TBtreatmentoutcomesbytypeoftreatment supervisionin Johannesburg,SouthAfrica.South AfricanJournalofInfectiousDiseases, 2015;30:69.

Chimbindi, N., Bor, J., Newell, M. L., Tanser, F., Baltusen, R., Hontelez, J., … & Bärnighausen, T. Time and money: the true costs of health care utilization for patients receiving ‘free’ HIV/TB care and treatment in rural KwaZulu-Natal. Journal of acquired immune deficiency syndromes. JAIDS, 2015; 70(20): e52- 60.

Cornell M, Johnson LF, Schomaker M, Tanser F, Maskew M, et al. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. Lancet HIV, 2015; 2(9) e368–e375.

Crump JA, Wu X Kendall MA, Ive PD, Kumwenda JJ, Grinsztejn B, Jentsch U, Swindells S. Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study. BMC Infect Dis, 2015 Jan 13;15(1):12.

d’Elia A, Evans D, McNamara L, Berhanu R, Sanne I, Lönnermark E. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa. Pan African Medical Journal, 2015; 22(4),6075.

De Neve, J. W., Fink, G., Subramanian, S. V., Moyo, S., &Bor, J. Length of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment. The Lancet Global Health. 2015, 3(8), e470-e477.

Dorji G, DeJong W, Bor J, DeSilva MB, Sabin L, Feeley FR, Udon P, Wangchuk N, Wangdi U, Choden T, Gurung MS, Chogyel T, Wangchuk D, Kypros K. Increasing compliance with alcohol service laws in a developing country: Intervention trial in the Kingdom of Bhutan. Addiction, 2015; 10.

Erlandson KM, Taejaroenkul S, Smeaton L, Gupta A, Singini II, Lama JR, Mngqibisa R, Firnhaber C, Cordoso SW, Kanyama C, da Silva ALM, Hakim JG, Kumarasamy N, Campbell TB, de Hughes M for the ACTG 5175/PEARL Study Team, A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings. Open Forum Infect Dis. 2015 Sep; 2(3):ofv095.

EvansD,BerhanuR,IveP,SpencerD,Firnhaber C,SanneI,FoxMP. Characteristicsof patientsonthird-lineantiretroviraltherapyfromJohannesburg,South Africa. SouthAfrican JournalofInfectiousDiseases,2015;30:68.

EvansD,MoyoF,NguwenazaA,LongL,FoxMP,BerhanuR. Adherenceinpatientsfailing secondlineARTusingan electronicpatientadherencemonitoringdeviceinJohannesburg, SouthAfrica.South AfricanJournalofInfectiousDiseases,2015;30:68.

Firnhaber C, Goeieman B, Faesen M, Levin S, Williams S, Rameotshela S, Swarts A, Michelow P, Omar T, Williamson AL, Allan B, Schnippel K, Smith JS. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa. PLoS One. 2016 Jan 5;11(1):e0144905. doi:10.1371/ journal.pone.0144905. eCollection 2016. PMID:26730710

Firnhaber C, Mao L, Levin S, Faesen M, Lewis DA, Goeieman BJ, Swarts AJ, Rakhombe N, Michelow PM, Williams S, Smith JS. Evaluation of a Cervicography-Based Program to Ensure Quality of Visual Inspection of Cervix in HIV-Infected Women in Johannesburg, Low Genit. Tract Dis., 2015 Jan; 19(1):7-11

Firnhaber C, Smeaton L, Grinsztejn B, Lalloo U, Faesen S, Samaneka W, Infante R, Rana A, Kumarasamy N, Hakim J, and Campbell T. Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial. HIV Clinical Trials 2015, 16(3): 88-89.

Fox MP, Rosen S. Systematic review of retention of paediatric patients on HIV treatment in low and middle-income countries 2008 – 2013. AIDS. 2015; 29(4): 493-502

Fox MP, Rosen S. Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle- Income Countries: Systematic Review and Meta-analysis 2008-2013. JAIDS 2015 May 1; 69(1):98-108.

Geng EH, Neilands TB, Thièbaut R, Bwana MB, Nash D, Moore RD, Wood R, Zannou DM, Althoff KN, Lim PL, Nachega JB, Easterbrook PJ, Kambugu A, Little F, Nakigozi G, Nakanjako D, Kiggundu V, Chung Ki Li P, Bangsberg DR, Fox MP, Prozesky HW, Hunt PW, Davies M, Reynolds SJ, Egger M, Yiannoutsos CT, Vittinghoff EV, Deeks SG, Martin JN. CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. Int. J. Epidemiology. 2015; 44 (1): 251-263.

Godfrey C, Firnhaber C, D’Souza G, Hear I. Anal Dysplasia in HIV Infected women: a commentary on the field. International Journal of STD & AIDS, November 2015.

Grimsrud Anna, Cornell Morna, Schomaker Michael, Fox Matthew P, Orrell Catherine, Prozesky Hans, Stinson Kathryn, Tanser Frank, Egger Matthias, Myer Landon,for the International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration (IeDEA-SA). CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study. J Epidemiol Community Health 2015;0:1–7.

Hanrahan C, Clouse K, Bassett J, Mutunga L, Selibas K, Stevens W, Scott L, Sanne I and Van Rie A. the patient impact of point-of care vs laboratory placement of Xpert MTB/RIF. Int J Tuberc Lung Dis 2015, 19 (7):811-816

Henegar CE, Westreich DJ, Maskew M, Miller WC, Brookhart MA, Van Rie A. Effect of Pregnancy and the Postpartum Period on Adherence to Antiretroviral Therapy Among HIV- Infected Women Established on Treatment. J Acquir Immune Defic Syndr 2015; 68:477–480

Henegar CE, Westreich D, Maskew M, Brookhart MA, Miller WC, Majuba P, Van Rie A. Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virological Failure. AIDS Behaviour. 2015; 19(4):612-8.

Huis t’ Veld D, Balestre E, Buyze J, Menten J, Jaquet A, Cooper DA, Dabis F, Yiannoutsos CT, Diero L, Mutevedzi P, Fox MP, et al. Determinants of weight evolution among HIV-positive patients initiating antiretroviral treatment in low-resource settings. J Acquir Immune Defic. Syndr. 2015: 70: 146-154

Johnson L.F, Dorrington R.E, Laubscher R, Hoffmann C.J, Wood R, Fox M.P, Cornell M, Schomaker M, Prozesky H, Tanser F, Davies M, Boulle A for the International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment. Journal of the International AIDS Society 2015, 18:20628. 16 December 2015.

Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Tripathy S, Wallis C, Rassool M, Pretreatment HIV Drug Resistance and HIV-1 Subtype C are independently associated with virologic failure: results from the multinational PEARLS (ACTG 5175) Clinical Trial. Clinical Infectious Diseases, May 2015, Volume 60, Number 10.

Koller M, Fatti G, Chi BH, Keiser O, Hoffmann CJ, Wood R, Prozesky H, Stinson K, Giddy J, Mutevedzi P, Fox M, Law M, Boulle A, Egger M. Risk charts to guide targeted HIV-1 viral load monitoring of ART: development and validation in patients from resource-limited settings. J Acquire Immune Deficiency Syndrome, 2015

Kumarasamy N, Aga E, Rabaudo H, Wallis Cl, Katzenstein D, Stevens W, Norton M, Klingman K, Hoseeinpour M, Crump J, Supparatpinyo K, Badal-Faesen S and Bartlett J. Lopinavir/ritonavir monotherapy as second-line antiretroviral treatment in resource limited settings-week 104 analysis of ACTG A5230. Clinical Infectious Diseases 2015.

Lince-Deroche N, Phiri J, Michelow P, Smith J.S., Firnhaber C. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa. PLOS ONE, 2015; 10.1371.

Lince-Deroche N, Constant D, Harries J, Blanchard K, Sinanovice E, Grossman D. The costs of accessing abortion in South Africa: women’s costs associated with second-trimester abortion services in Western Cape Province. Contraception. 2015; 15: 2: S0010-7824

Lince-Deroche N, Hargey A, Holt K, Shochet T. Accessing Sexual and Reproductive Health Information and Services: A Mixed Methods Study of Young Women’s Needs and Experiences in Soweto, South Africa. African Journal of Reproductive Health. 2015 March; 19 (1): 73

Luetkemeyer AF, Rosenkrantz SL, Lu D, Grinsztejn B, Sanchez J, Ssemmanda M, Sanne I, McIlleron, Havlir DV, and Haas DW. The Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams. Combined effect of CYP2B6 and NAT2 genotype on plasma Efavirenz exposure during rifampicin-based anti-tuberculosis therapy in STRIDE study. Clinical Infectious Diseases.

Mahomed S, Behrens K, Slabbert M and Sanne I. Managing human tissue transfer across national boundaries – an approach from an institution in South Africa. Dev World Bioethics 2015, epub ahead of print.

Marseille E, Larson B, Kazi DS, Kahnd JG, Rosen S. Thresholds for the cost– effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015; 93:118–124

Maughan-Brown B, Lloyd N, Bor J, Venkataramani A. Increasing access to HIV testing: Impacts on equity of coverage and uptake from a national campaign in South Africa. Southern Africa Labour and Development Research Unit, University of Cape Town 2015. SALDRU Working Paper 145.

Mohr E, Evans D, Shearer K, Spencer D, Fox MP. Definitions of virologic failure in a cohort of HIV-positive patients on first-line antiretroviral therapy in Johannesburg, South Africa. South African Journal of Infectious Diseases. 2015; 30: 69.

Moscoe, E., Bor, J., & Bärnighausen, T. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. Journal of clinical epidemiology. 2015, 68(2), 122- 133.

Meyer-Rath G, Pienaar J, Brink B, van Zyl A, Muirhead D, Grant A, Muirhead D, Grant A, Churchyard G, Watts C, Vickerman P. The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis. PLoS Med. 2015 12(9): e1001869

Naidoo S, Evans D, Jong E, Mellet K, Berhanu R. Outcomes of TB/HIV co- infected patients presenting with anti-tuberculosis drug-induced liver injury. S Afr Med Journal. 2015; 105:393- 96.

Ndjeka N, Conradie F, Schnippel K, Hughes J, Bantubani N, Ferreira H, Maartens G, Mametja D, Meintjies G, Padanilam X, Variava E, Pym A, and Pillay Y. Treatment of drug-resistant tuberculosis with bedaqualine in a high HIV prevalence setting: an interim cohort analysis. Int J TUberc and lung Dis 2015, 19(8): 979-985

Onyango MA, Adu-Sarkodie Y, Agyarko-Poku T, Asafo MK, Sylvester J, Wondergem P, Green K, Wambugu S, Brennan AT, Beard J. “It’s all about making a life”: poverty, HIV, violence, and other vulnerabilities faced by young female sex workers in Kumasi, Ghana. J Acquir Immune Defic Syndr. 2015 Mar 1; 68 (2):S131-7.

Platt M.O, Evans D, Keegan P.M, McNamara L, Parker I.K, Roberts, LaDeidra M, Caulk A.W., Gleason Jr R.L., Seifu D, Amogne W, Penny C. Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography. Springer Mol Biotechnol.

Podany AT, Bao Y, Swindells S, Chaisson RE< Andersen JW, Mwelase N et al. Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention. Clinical Infectious Diseases, 2015 Oct, 61(2):1322-1327

Rehle T, Johnson L, Hallett T, Mah, M, Kim A, Odido H, Onoya D, Jooste S, Shisana O, Puren A, Parekh B, Stover J. A comparison of South African national HIV incidence estimates: a critical appraisal of different methods. PLoS ONE, 2015; 10: 7:e0133255.

Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J; With the A5271 study team, Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A; International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.AIDS Clinical Trials Group. J Neurovirol. 2016 Jan 5. PMID:26733457

Rosenberg M, Pettifor A, Nguyen N, Westreich D, Bor J, Bärnighausen T, Mee P, Twine R, Tollman S, Kahn K. Relationship between Receipt of a Social Protection Grant for a Child and Second Pregnancy Rates among South African Women: A Cohort Study. PLoS One. 2015; 10(9):e0137352.

Schnippel K, Mongwenyana C, Long L, Larson A. Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis. BMC Infectious Diseases. 2015 February 06: 15; 46

Schnippel K, Lince-Deroche N, van den Handel T, Molefi S, Bruce S, Firnhaber C. Cost Evaluation of Reproductive and Primary Health Care Mobile Service Delivery for Women in Two Rural Districts in South Africa. PLoS One. 2015 Mar 9; 10(3):e0119236

Schnippel K, Shearer K, Evans D, Berhanu R, Dlamini S, Ndjeka N. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register. Int J Infect Dis. 2015; 39:89-94.

Schnippel K, Michelow P, Chibwesha C J, Makura C, Lince-Deroche N, Goeieman B, Mulongo M, Jordaan S, Firnhaber C. Cost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis. BMC Health Services Research 2015; 15:499

Tenforde MW, Gupte N, Dowdy DW, N Mwelase et al. C reactive protein, interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with rish tuberculosis after initiation of antiretroviral therapy in resource-limited settings. 2015 February, PLoS One; 10 (2).

Van den Handel T, Hampton K, Sanne I, Stevens W, Crous R and Van Rie A. the impact of Xpert MTB/RIF in sparsely populated rural settings. Int J Tuberculosis Lung Disease 2015, 19(4): 392-398.

Yotebieng M, Maskew M and Van Rie A. CD4+ gain percentile curves for monitoring resources to antiretroviral therapy in HIV_infected adults. AIDS 2015, 29(0); 1067-1075.

Zumla A, Chakaya J, Holescher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeaboah-Manu D, Rasolof V, Munderi P, Sanne I, et al. Towards host-directed therapies for tuberculosis. National Review of Drug Discovery, 2015, July, Volume 14, Pages 511-512